PemOla awarded grant on World Pancreatic Cancer Day
16 November 2023 We are thrilled to announce the PemOla clinical trial, led by Dr Daniel Croagh, has received... Read More
Changes to the AGITG Board – thank you and welcome
With recent changes to the AGITG Board of Directors, the team would like to express our heartfelt gratitude... Read More
New community-funded research aims to reduce treatment burden for rectal cancer patients
Thanks to the trust, dedication and support of the GI cancer community, up to $200,000 has been awarded... Read More
Distant and disparate: rural, regional and remote access to cancer care
Russell may already be familiar to you as our Chief Executive Officer. In this feature, we cover his... Read More
Oesophageal cancer: symptoms and risk factors
Oesophageal cancer is not as well known as some other forms of cancer, but over 1,400 Australians lose... Read More
DYNAMIC-III trial could provide more effective screening
The potential of liquid biopsies in cancer screening will be tested in the DYNAMIC-III trial, which is... Read More
Colorectal cancer research at the GI Cancer Institute
Australia has one of the highest incidences of colorectal cancer in the world. Also known as bowel cancer,... Read More
What is cholangiocarcinoma?
February is Gallbladder and Bile Duct Cancer Awareness Month and World Cholangiocarcinoma Awareness Day. In everyday life, most... Read More
An exciting year for gut microbiome research
A translational research update from Dr Sarah Hayes: I am pleased to report that 2022 has been... Read More
RESOLUTE trial: a community victory for personalised cancer treatment
As GI cancer research progresses, the importance of precise, personalised cancer treatment is becoming increasingly apparent through our... Read More
Community-funded, Phase II trial PALEO helping oesophageal cancer patients swallow without pain
For people with advanced oesophageal cancer, one of the first side effects is dysphagia: difficulty or pain in... Read More
The Innovation Grant: Where your donations go
The GI Cancer Institute Innovation Grant was created to support new research into GI cancer treatments. It is... Read More
Welcoming Christie Ah-Fa as a member of the Community Advisory Panel
In September 2022, the Community Advisory Panel (CAP) welcomed Christie Ah-Fa as a member. Christie was introduced... Read More
Member Spotlight: Professor Rob Ramsay
Professor Rob Ramsay is Head of the Differentiation and Transcription Laboratory at Peter MacCallum Cancer Centre, Melbourne. He... Read More
Welcoming Sandra Bahamad to the team
Sandra recently joined the AGITG and GI Cancer Institute as Clinical Trials Project Manager. HOW DID YOU COME TO... Read More
Community Spotlight: Mental Health Month for clinicians
October is Mental Health Month in Australia, and this month we are shining our community spotlight on mental... Read More
Research breakthroughs in stomach and oesophageal cancer
One exciting development has us very hopeful. A novel protein marker known as STING has been found to... Read More
Member Spotlight: Associate Professor Haryana Dhillon
Associate Professor Haryana Dhillon is a behavioural scientist and psycho-oncologist at the University of Sydney, working with people... Read More
Member Spotlight: Dr Manju Chandrasegaram
Manju is a HPB and General Surgeon at the Prince Charles Hospital in Brisbane since 2015. She completed... Read More
Member Spotlight: Associate Professor Marion Harris
Associate Professor Marion Harris is a medical oncologist working with GI and breast cancer and has been Director... Read More